Nova In Silico is a biotechnology company specializing in advanced computational methods for drug discovery and development. The company leverages artificial intelligence and machine learning to enhance the efficiency and accuracy of predicting molecular interactions, optimizing drug candidates, and streamlining the research and development process. Nova In Silico aims to facilitate innovation in pharmaceutical research by providing data-driven insights and solutions that accelerate the journey from concept to clinical application.